Mechanism of agonistic angiotensin II type I receptor autoantibody-amplified contractile response to Ang II in the isolated rat thoracic aorta

Acta Biochimica Et Biophysica Sinica
Wenhui ZhangJianming Zhi

Abstract

Agonistic autoantibody to the angiotensin II type I receptor (AT1-AA) is highly associated with preeclampsia by increasing the sensitivity of Ang II during pregnancy in rats, thus leading to a preeclampsia-like syndrome. However, the mechanism underlying this phenomenon remains unclear. The purpose of this study was to observe AT1-AA amplification of Ang II-induced vasoconstriction in rat thoracic aortic rings. It was found that exposure to low concentrations of AT1-AA (0.4 nM) caused a contraction of <5% of the maximal response to 60 mM KCl. In addition, the Ang II-induced contractile response was amplified in the presence of a threshold contraction to AT1-AA, as manifested by a leftward shift of the midpoint of the concentration-response curve with no change in the maximal response. These results showed that preincubation with low AT1-AA could amplify the Ang II dose-response curve, and this amplification could be attenuated markedly by 0.1 µM heptapeptide AFHYESQ. In calcium-free Krebs solution, 10 µM of 2-aminoethoxydiphenyl borate (an IP3 receptor inhibitor) both blocked the AT1-AA base contraction and completely abolished the amplification. Both 5 µM of U-73122 (a phospholipase C inhibitor) and 10 µM of εV1-2 (an εPKC inh...Continue Reading

References

Nov 22, 1997·Hypertension·F Broughton Pipkin, P N Baker
Apr 9, 1999·The Journal of Clinical Investigation·G WallukatF C Luft
Nov 6, 2004·Seminars in Nephrology·Ralf DechendFriedrich C Luft
Sep 5, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Yan-Xia WangYi-Chun Zhu
Apr 11, 2007·Current Opinion in Nephrology and Hypertension·Dinesh M Shah
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Lauren Anton, K Bridget Brosnihan
Jun 12, 2009·Reproductive Sciences·Ravi GoyalLawrence D Longo
Jun 13, 2009·Endocrinology·Lauren AntonK Bridget Brosnihan
Feb 15, 2011·Current Opinion in Pharmacology·Babbette LaMarcaJoey Granger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.